Catalyst Pharma Files SEC Form
Catalyst Pharmaceuticals files preliminary proxy statement with SEC. The filing may indicate upcoming corporate actions or changes.
Filed: 2026-05-28 AccNo: 0001193125-26-245426 Size: 2 MB
Catalyst Pharmaceuticals files preliminary proxy statement with SEC. The filing may indicate upcoming corporate actions or changes.
Filed: 2026-05-28 AccNo: 0001193125-26-245426 Size: 2 MB